• Topic
  • Category
  • Keyword

VION Biosciences Acquires Second Asset in August, Immunoassay Development Company Ansh Labs

3 minutes
V (2)
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proidentsunt.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim id est laborum. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim estem laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatnon proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim id est laborum. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim estem laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatnon proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum.

Vion proudly supports a group of pioneering companies that are advancing science, healthcare, and technology.

Anthony Science

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim id est laborum. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim estem laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatnon proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim id est laborum. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eufugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt inculpa qui officia deserunt mollit anim estem laborum. Duis aute irure dolor in reprehen deritin voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatnon proident, sunt in culpa quiofficia deserunt mollit animid esteno laborum.

about-banner

Related Articles

VION Biosciences Acquires Enzymatic Assay Innovator BioAssay Systems

NASHVILLE, Tenn.--(BUSINESS WIRE)--VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, announced its January 2025 acquisition of San Francisco area-based BioAssay Systems, a biotech company that develops and offers innovative high-throughput assay solutions for life sciences and drug discovery. This acquisition serves as the fourth investment under the VION platform, continuing its growth in developing proprietary products for life science research.
Favicon

VION Biosciences Names Vince Stoyanov as Chief Strategy and Development Officer

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, today announced Vince Stoyanov as its Chief Strategy and Development Officer. He will lead corporate development, mergers and acquisitions (M&A), and other related corporate functions, bringing both expertise and continued energy to VION at a critical moment in its expansion efforts.

VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC (“VION Biosciences”), Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.
V

Empowering
a World
of Discovery

Join us in advancing life sciences and creating transformative solutions.

footer-logo

© VION Biosciences. All rights reserved.